HRS9531 tablets
Phase 1
HRS9531 tablets is one of 4 therapeutic programs targeting Weight Management. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
5 competitors in Weight Management
#DrugCompanyPhaseTrials
1Elecoglipron
AstraZenecaPhase 3
Prilosec
DDexcel Pharma Technologies Ltd.
Phase 1
GS-4571
GileadPhase 1
HRS9531 tablets
FFujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for HRS9531 tablets. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 1[1]